STEINERT DISEASE
Clinical trials for STEINERT DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEINERT DISEASE trials appear
Sign up with your email to follow new studies for STEINERT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug DYNE-101 aims to ease muscle symptoms in DM1
Disease control Recruiting nowThis Phase 3 trial tests whether DYNE-101 can improve muscle function and daily life in 150 adults with myotonic dystrophy type 1 (DM1). Participants receive either the drug or a placebo by IV every few weeks for 48 weeks. The study measures how quickly people can stand from a ch…
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Spanish researchers launch massive DM1 registry to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to create a national registry for people with Myotonic Dystrophy Type 1 (DM1) in Spain. Researchers will collect clinical data, genetic information, and patient reports from up to 3,000 participants. The goal is to better understand the disease and identify people…
Matched conditions: STEINERT DISEASE
Sponsor: Fundació Institut Germans Trias i Pujol • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC